tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market
ONCY
Oncolytics Biotech
RESEARCH TOOLSreports
Want to see ONCY full AI Analyst Report?

Oncolytics Biotech (ONCY) Stock News & Sentiment

1,562 Followers
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
Premium
Ratings
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
9h ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
Premium
Company Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
18d ago
8K
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
Premium
Company Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
25d ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
Premium
Ratings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
1M ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
Premium
Company Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
2M ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
Premium
Company Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
2M ago
8K
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
Premium
Company Announcements
Oncolytics Biotech Completes Domestication to Nevada with New Governance
2M ago
8K
ONCY
More ONCY News >

ONCY News on the Web

Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Nurix Therapeutics (NRIX)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Oncolytics Biotech (ONCY)
TipRanks News
Neutral
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Oncolytics price target lowered to $5 from $7 at Lake Street
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)
TipRanks News
Neutral
Oncolytics Biotech Establishes $75 Million ATM Offering
TipRanks News
Neutral
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
ONCY
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ONCY’s Media Buzz Sentiment?
1 articles about ONCY were published this week. In an average week, 1.5 articles are published.
    What is ONCY’s weekly average amount of articles?
    In an average week, 1.5 articles about ONCY are published.
      What is ONCY’s News Sentiment?
      100% of articles about ONCY were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        Showing the stocks with the most bullish news sentiment over the past week